Following Norway, Which Market Will Be Next to See Extreme Biosimilar Discounting?
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1692
https://www.valueinhealthjournal.com/article/S1098-3015(15)03768-7/fulltext
Title :
Following Norway, Which Market Will Be Next to See Extreme Biosimilar Discounting?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03768-7&doi=10.1016/j.jval.2015.09.1692
First page :
A538
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1121